Comment on

• Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation.

  Stangou AJ, Banner NR, Hendry BM, Rela M, Portmann B, Wendon J, Monaghan M, Maccarthy P, Buxton-Thomas M, Mathias CJ, Liepnieks JJ, O'Grady J, Heaton ND, Benson MD. Stangou AJ, et al. Blood. 2010 Apr 15;115(15):2998-3007. doi: 10.1182/blood-2009-06-223792. Epub 2009 Jul 24. Blood. 2010. PMID: 19633201
• Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis.

  Kastritis E, Wechalekar AD, Dimopoulos MA, Merlini G, Hawkins PN, Perfetti V, Gillmore JD, Palladini G. Kastritis E, et al. J Clin Oncol. 2010 Feb 20;28(6):1031-7. doi: 10.1200/JCO.2009.23.8220. Epub 2010 Jan 19. J Clin Oncol. 2010. PMID: 20085941
• Long-term TNF-alpha blockade in patients with amyloid A amyloidosis complicating rheumatic diseases.

  Fernández-Nebro A, Olivé A, Castro MC, Varela AH, Riera E, Irigoyen MV, García de Yébenes MJ, García-Vicuña R. Fernández-Nebro A, et al. Am J Med. 2010 May;123(5):454-61. doi: 10.1016/j.amjmed.2009.11.010. Am J Med. 2010. PMID: 20399323 Clinical Trial.
• Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

  Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Coppéré B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P. Saadoun D, et al. Blood. 2010 Jul 22;116(3):326-34; quiz 504-5. doi: 10.1182/blood-2009-10-248518. Epub 2010 May 3. Blood. 2010. PMID: 20439619 Clinical Trial.